Annotated Medicine and Device Lists


Tamoxifen

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
citrate INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 09.04. HORMONAS SEXUALES FEMENINAS No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 18.02. TRATAMIENTO HORMONAL DEL CÁNCER No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 02 TERAPIA ENDÓCRINA No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 30 TABLETAS
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 02. TERAPIA ENDÓCRINA No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.03. HORMONAS Y ANTIHORMONAS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 8.2.4. Hormones and antihormones No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Ecuador Essential Medicines List - Ecuador No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 08.06 HORMONE ANTAGONISTS No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.03. HORMONAS Y ANTIHORMONAS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 8.2.4. Hormones and antihormones No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 8.3 Hormones and Antihormones No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti Estrogens No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 41. Antineoplásicos y agentes inmunomoduladores No observations
El Salvador - 2019 AGENTES DE TERAPIA ENDOCRINA No observations

Information Resources: Tamoxifen

Loading ...
Loading ...
Loading ...
No information available